title: Oral delivery of biologically active parathyroid hormone.
abstract: OBJECTIVE
  Parathyroid hormone (PTH), the only drug known to stimulate bone formation. is a peptide therapeutic indicated in the treatment of osteoporosis. Unfortunately, PTH is only effective when dosed by injection because it has no oral bioavailability. Herein we report the oral absorption of PTH in rats and monkeys facilitated by the novel delivery agent, N-[8-(2-hydroxy-4-methoxy)bensoyl]amino caprylic acid (4-MOAC).
  
  
  METHODS
  4-MOAC was selected from a group of 100 delivery agents based on in vitro chromotography studies and in vivo screening studies in rats. The PTH/4-MOAC combination was then tested in monkeys. The interaction of 4-MOAC and PTH was evaluated by nuclear magnetic resonance (NMR) spectroscopy.
  
  
  RESULTS
  Monkeys were administered an aqueous solution containing 4-MOAC and PTH and mean peak serum PTH concentrations of about 3000 pg/mL were obtained. The relative bioavailability of oral PTH was 2.1% relative to subcutaneous administration. The biological activity of the orally-delivered PTH was further evaluated in a rat model of osteoporosis. These studies showed that the bone formed following oral PTH/4-MOAC administration was comparable to that formed following PTH injections. The 4-MOAC mediated absorption of PTH is hypothesized to be the result of a noncovalent interaction between 4-MOAC and PTH. The preliminary evaluation of this interaction by NMR is described.
  
  
  CONCLUSIONS
  4-MOAC facilitates the absorption of PTH following oral administration to both rats and monkeys. The orally-absorbed PTH is biologically active as demonstrated in a rat model of osteoporosis.
authors.affiliation: Emisphere Technologies, Inc, Tarrytown, New York 10591, USA. aleone-bay@emisphere.com
authors.forename: A
authors.initials: A
authors.lastname: Leone-Bay
authors.forename: M
authors.initials: M
authors.lastname: Sato
authors.forename: D
authors.initials: D
authors.lastname: Paton
authors.forename: A H
authors.initials: AH
authors.lastname: Hunt
authors.forename: D
authors.initials: D
authors.lastname: Sarubbi
authors.forename: M
authors.initials: M
authors.lastname: Carozza
authors.forename: J
authors.initials: J
authors.lastname: Chou
authors.forename: J
authors.initials: J
authors.lastname: McDonough
authors.forename: R A
authors.initials: RA
authors.lastname: Baughman
mesh_terms: D000284:Administration, Oral; D000818:Animals; D002210:Caprylates / Q000008:administration & dosage* / Q000737:chemistry; D016503:Drug Delivery Systems / Q000379:methods*; D005260:Female; D007408:Intestinal Absorption / Q000502:physiology; D008253:Macaca mulatta; D008297:Male; D019906:Nuclear Magnetic Resonance, Biomolecular; D010024:Osteoporosis / Q000188:drug therapy; D010281:Parathyroid Hormone / Q000008:administration & dosage* / Q000097:blood; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D002210:Caprylates; D010281:Parathyroid Hormone